Project Grant HT9425261E149
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $840K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- Federal Project Grant Award Summary The University of Melbourne received a $721,656 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective November 1, 2025, through October 31, 2028. This award funds research on minimally-invasive measurement of pressure dynamics in the brain following traumatic brain injury (TBI). The research will be conducted at the University of Melbourne's facility in Australia and represents...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on June 1, 2026, with a completion date of May 31, 2029. This award supports the development of a Schwann cell-derived extracellular vesicle platform designed to advance biomarker discovery for amyotrophic lateral sclerosis (ALS) in...
- Federal Grant Award Summary The University of Michigan received a $838,945 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2026, through June 30, 2028. The award supports research addressing TDP43-dependent disease mechanisms in amyotrophic lateral sclerosis (ALS) through selective pharmacological cochaperones. This research initiative will be conducted at the University of Michigan's Ann Arbor...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $939,325 to the Weizmann Institute of Science on November 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to support the GLOBALS (Global Omic Biomarker Research for ALS) initiative. This three-year project, extending through October 31, 2028, funds advanced biomedical research focused on discovering and developing omic biomarkers for amyotrophic lateral sclerosis (ALS). The research...
- Federal Grant Award Summary Emory University received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2028. The award supports research focused on "Repurposing Approved Drugs as First-in-Class Disruptors of the P38/MK2 Complex to Suppress Neuroinflammation in ALS" (amyotrophic lateral sclerosis). The research will be conducted at Emory University's...
- Federal Grant Award Summary The University of Massachusetts Medical School (UMMS) received a $836,992 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to investigate the effects of military-associated environmental toxins on motor neurons and glial cells in sporadic amyotrophic lateral sclerosis (ALS). The award, effective August 1, 2025, through July 31, 2028, supports hypothesis-driven biomedical research...
- The Defense Health Agency awarded a $659,922 Project Grant to Macquarie University in Australia under the Military Medical Research and Development program (CFDA 12.420). The grant funds a gene therapy research project aimed at developing a treatment for delaying the onset of Amyotrophic Lateral Sclerosis (ALS) through nuclear TDP-43 supplementation. The research will be conducted at Macquarie University over a 2-year period from September 2025 to September 2027. This project grant is part of...
- Federal Grant Award Summary La Trobe University received a $669,102 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), with an award date of April 1, 2026 and completion date of March 31, 2029. The project, titled "Using Novel Biological Therapies to Target a Tumor-Specific Isoform of HER2 for the Treatment of Advanced Breast Cancer," focuses on developing and advancing innovative therapeutic approaches to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of California, Davis a $2.8 million project grant under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2029. This award supports the development of a consistently intelligible brain-computer interface (BCI) voice synthesis system designed for individuals with amyotrophic lateral sclerosis (ALS). The project will be conducted at UC Davis's Davis,...
- Federal Grant Award Summary Case Western Reserve University's Office of Research Administration received a $839,998 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2026, with a performance period through June 30, 2028. The award supports research into pharmacological stabilization of the calpain-2 complex as a novel translational therapeutic approach for amyotrophic lateral sclerosis (ALS). This...